Crescita Therapeutics Inc.
CRRTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $12,444 | $7,362 | $13,460 | $13,320 |
| - Cash | $9,273 | $9,385 | $8,238 | $11,331 |
| + Debt | $834 | $1,254 | $1,613 | $2,868 |
| Enterprise Value | $4,005 | -$769 | $6,835 | $4,857 |
| Revenue | $19,580 | $17,522 | $23,525 | $16,769 |
| % Growth | 11.7% | -25.5% | 40.3% | – |
| Gross Profit | $9,608 | $10,364 | $13,182 | $10,014 |
| % Margin | 49.1% | 59.1% | 56% | 59.7% |
| EBITDA | -$1,333 | -$450 | $2,000 | $606 |
| % Margin | -6.8% | -2.6% | 8.5% | 3.6% |
| Net Income | -$2,750 | -$1,986 | $862 | -$1,105 |
| % Margin | -14% | -11.3% | 3.7% | -6.6% |
| EPS Diluted | -0.14 | -0.098 | 0.041 | -0.053 |
| % Growth | -42.9% | -338.4% | 177.3% | – |
| Operating Cash Flow | $2,725 | $2,076 | -$1,020 | -$1,597 |
| Capital Expenditures | -$1,185 | -$133 | -$229 | -$346 |
| Free Cash Flow | $1,540 | $1,943 | -$1,249 | -$1,943 |